PMC Articles for MedGen (Select 825713) - PMC

Links from MedGen

Items: 1 to 20 of 110

<< First< Prev

Page of 6

Select item 106191961.

Altered expression of imprinted genes in patients with cytogenetically normal‑acute myeloid leukemia: Implications for leukemogenesis and survival outcomes

Ming-Yu Yang, Cheng-Ming Hsu, Pai-Mei Lin, Chao-Hui Yang, Ming-Luen Hu, I-Ya Chen, Sheng-Fung Lin

Mol Clin Oncol. 2023 Dec; 19(6): 94. Published online 2023 Oct 5. doi: 10.3892/mco.2023.2690

PMCID:: PMC10619196

Abstract Article PDF–1.4M

Select item 102252402.

The impact of DNMT3A variant allele frequency and two different comutations on patients with de novo cytogenetically normal acute myeloid leukemia

Xian Chen, Chuchu Tian, Zhuanghui Hao, Lingang Pan, Minglin Hong, Wei Wei, Daniel Muteb Muyey, Hongwei Wang, Xiuhua Chen

Cancer Med. 2023 May; 12(9): 10340–10350. Published online 2023 Mar 13. doi: 10.1002/cam4.5764

PMCID:: PMC10225240

Abstract Article PDF–3.1M

Select item 99714783.

Clinical Implication of DNMT3A and TET2 Genes Mutations in Cytogenetically Normal Acute Myeloid Leukemia

Salah Aref, Nahed Sallam, Sherin Abd Elaziz, Osama Salama, Shaimaa Al Ashwah, Mohamed Ayed

Asian Pac J Cancer Prev. 2022 Dec; 23(12): 4299–4305. doi: 10.31557/APJCP.2022.23.12.4299

PMCID:: PMC9971478

Abstract Article PDF–882K

Select item 90578264.

Overexpression of Prohibitin 2 Protein is Associated with Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia

Young Eun Lee, Ha Jin Lim, Ju Heon Park, Hye Ran Kim, Min-Gu Kang, Young Kuk Cho, Jong Hee Shin, Myung Geun Shin

Ann Lab Med. 2022 Sep 1; 42(5): 585–589. Published online 2022 Sep 1. doi: 10.3343/alm.2022.42.5.585

PMCID:: PMC9057826

Abstract Article PDF–1.3M

Select item 90528955.

Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemia

Dimitrios Papaioannou, Hatice G. Ozer, Deedra Nicolet, Amog P. Urs, Tobias Herold, Krzysztof Mrózek, Aarif M.N. Batcha, Klaus H. Metzeler, Ayse S. Yilmaz, Stefano Volinia, Marius Bill, Jessica Kohlschmidt, Maciej Pietrzak, Christopher J. Walker, Andrew J. Carroll, Jan Braess, Bayard L. Powell, Ann-Kathrin Eisfeld, Geoffrey L. Uy, Eunice S. Wang, Jonathan E. Kolitz, Richard M. Stone, Wolfgang Hiddemann, John C. Byrd, Clara D. Bloomfield, Ramiro Garzon

Haematologica. 2022 May 1; 107(5): 1034–1044. Published online 2021 Jul 15. doi: 10.3324/haematol.2020.266643

PMCID:: PMC9052895

Abstract Article PDF–3.1M

Select item 89429836.

Revealing key lncRNAs in cytogenetically normal acute myeloid leukemia by reconstruction of the lncRNA–miRNA–mRNA network

Tao Sun, Lin Dong, Yan Guo, Hai Zhao, Manzhi Wang

Sci Rep. 2022; 12: 4973. Published online 2022 Mar 23. doi: 10.1038/s41598-022-08930-6

PMCID:: PMC8942983

Abstract Article PDF–4.7M

Select item 85734747.

Higher Expression of WT1 With Lower CD58 Expression may be Biomarkers for Risk Stratification of Patients With Cytogenetically Normal Acute Myeloid Leukemia

Cunte Chen, Zhuowen Chen, Chi Leong Chio, Ying Zhao, Yongsheng Li, Zhipeng Liu, Zhenyi Jin, Xiuli Wu, Wei Wei, Qi Zhao, Yangqiu Li

Technol Cancer Res Treat. 2021; 20: 15330338211052152. Published online 2021 Nov 5. doi: 10.1177/15330338211052152

PMCID:: PMC8573474

Abstract Article PDF–2.3M

Select item 84641598.

Comprehensive analysis of mutations and clonal evolution patterns in a cohort of patients with cytogenetically normal acute myeloid leukemia

Yuslina Mat Yusoff, Fadly Ahid, Zahidah Abu Seman, Julia Abdullah, Nor Rizan Kamaluddin, Ezalia Esa, Zubaidah Zakaria

Mol Cytogenet. 2021; 14: 45. Published online 2021 Sep 24. doi: 10.1186/s13039-021-00561-2

PMCID:: PMC8464159

Abstract Article PDF–1.6M

Select item 84159129.

Risk Stratification of Cytogenetically Normal Acute Myeloid Leukemia With Biallelic CEBPA Mutations Based on a Multi-Gene Panel and Nomogram Model

Li-Xin Wu, Hao Jiang, Ying-Jun Chang, Ya-Lan Zhou, Jing Wang, Zi-Long Wang, Lei-Ming Cao, Jin-Lan Li, Qiu-Yu Sun, Shan-Bo Cao, Feng Lou, Tao Zhou, Li-Xia Liu, Cheng-Cheng Wang, Yu Wang, Qian Jiang, Lan-Ping Xu, Xiao-Hui Zhang, Kai-Yan Liu, Xiao-Jun Huang, Guo-Rui Ruan

Front Oncol. 2021; 11: 706935. Published online 2021 Aug 17. doi: 10.3389/fonc.2021.706935

PMCID:: PMC8415912

Abstract Article PDF–1.2M

Select item 838107510.

RUNX1 mutation and elevated FLT3 gene expression cooperates to induce inferior prognosis in cytogenetically normal acute myeloid leukemia patients

Atia Rehman, Afia Muhammad Akram, Asma Chaudhary, Nadeem Sheikh, Zawar Hussain, Walaa F. Alsanie, Rahat Abdul Rehman, Naila Hameed, Tayyaba Saleem, Amjad Zafar, Muhammad Absar, Zafar Iqbal, Alaa Alhazmi, Hosam Ali Baeshen, Zuhair M Mohammedsaleh, Samina Qamer, Samy Sayed, Ahmed Gaber

Saudi J Biol Sci. 2021 Sep; 28(9): 4845–4851. Published online 2021 Jul 10. doi: 10.1016/j.sjbs.2021.07.012

PMCID:: PMC8381075

Abstract Article PDF–1.4M

Select item 819039611.

Prognostic Prediction of Cytogenetically Normal Acute Myeloid Leukemia Based on a Gene Expression Model

Liu Yang, Houyu Zhang, Xue Yang, Ting Lu, Shihui Ma, Hui Cheng, Kuangyu Yen, Tao Cheng

Front Oncol. 2021; 11: 659201. Published online 2021 May 27. doi: 10.3389/fonc.2021.659201

PMCID:: PMC8190396

Abstract Article PDF–8.4M

Select item 794828812.

Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemia

Christopher J. Walker, Krzysztof Mrózek, Hatice Gulcin Ozer, Deedra Nicolet, Jessica Kohlschmidt, Dimitrios Papaioannou, Luke K. Genutis, Marius Bill, Bayard L. Powell, Geoffrey L. Uy, Jonathan E. Kolitz, Andrew J. Carroll, Richard M. Stone, Ramiro Garzon, John C. Byrd, Ann-Kathrin Eisfeld, Albert de la Chapelle, Clara D. Bloomfield

Blood Adv. 2021 Mar 9; 5(5): 1474–1482. Published online 2021 Mar 8. doi: 10.1182/bloodadvances.2020003727

PMCID:: PMC7948288

Abstract Article PDF–1.4M

Select item 759982613.

DNA Repair Expression Profiling to Identify High-Risk Cytogenetically Normal Acute Myeloid Leukemia and Define New Therapeutic Targets

Ludovic Gabellier, Caroline Bret, Guillaume Bossis, Guillaume Cartron, Jérôme Moreaux

Cancers (Basel) 2020 Oct; 12(10): 2874. Published online 2020 Oct 6. doi: 10.3390/cancers12102874

PMCID:: PMC7599826

Abstract Article PDF–4.1M

Select item 754009814.

Methylation-independent CRIP1 expression is a potential biomarker affecting prognosis in cytogenetically normal acute myeloid leukemia

Bei-Bei Ma, Ting-Juan Zhang, Cui-Zhu Wang, Zi-Jun Xu, Jing-Dong Zhou, Yu Gu, Ji-Chun Ma, Zhao-Qun Deng, Jiang Lin, Jun Qian

Am J Transl Res. 2020; 12(9): 4840–4852. Published online 2020 Sep 15.

PMCID:: PMC7540098

Abstract Article PDF–2.7M

Select item 750785915.

Aberrant Chloride Intracellular Channel 4 Expression Is Associated With Adverse Outcome in Cytogenetically Normal Acute Myeloid Leukemia

Sai Huang, Zhi Huang, Ping Chen, Cong Feng

Front Oncol. 2020; 10: 1648. Published online 2020 Sep 9. doi: 10.3389/fonc.2020.01648

PMCID:: PMC7507859

Abstract Article PDF–3.9M

Select item 748668116.

High frequency of rare structural chromosome abnormalities at relapse of cytogenetically normal acute myeloid leukemia with FLT3 internal tandem duplication

Theodore S. Gourdin, Ying Zou, Yi Ning, Ashkan Emadi, Vu H. Duong, Michael L. Tidwell, Ching Chen, Feyruz V. Rassool, Maria R. Baer

Cancer Genet. Author manuscript; available in PMC 2020 Sep 12.

Published in final edited form as: Cancer Genet. 2014 Oct-Dec; 207(10-12): 467–473. Published online 2014 Sep 16. doi: 10.1016/j.cancergen.2014.09.001